Optex Systems Holdings, Inc. - Common Stock (OPXS)
Healthcare › Optical Instruments & Lenses
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- Trading 92% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 17.6% — good return on equity
- Revenue growing at 22% annually
Optex Systems Holdings, Inc. - Common Stock (OPXS) is a Healthcare company operating in Optical Instruments & Lenses, listed on the NASDAQ , with a market capitalisation of $95 million . Key value metrics: P/E ratio 21.7, P/B ratio 3.82, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Optex Systems Holdings, Inc. - Common Stock — Fundamental Analysis Summary
Optex Systems Holdings, Inc. - Common Stock (OPXS) is currently trading 92% above its Graham Number of $7.11, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 21.7x.
On financial health, OPXS shows a moderate Piotroski F-Score of 4/9, and solid return on equity of 17.6% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.22.
StockPik's composite Value Score for OPXS is 66/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
OPXS reports a moderate gross margin of 27.4% (sector average: 33.5%) and a solid operating margin of 13.3%.
OPXS shows revenue growing at 22% year-over-year, with earnings growing at 37%.